Spring direct naar de hoofdnavigatie of de inhoud

Tech starters

As a starting high-tech or biotech company, your focus is on developing an idea into a market product. At the same time, you want to ensure the survival of your company through a good funding position. To ensure this, experimental proof of your ideas is crucial; this way you ensure a strong position of your intellectual property. V.O. helps manage your intellectual property and fully exploit your position in this area.

V.O. guides and advises you in optimizing the position of your intellectual property in line with your company's strategy. We also offer support in building and successfully managing a healthy intellectual property portfolio. We take charge of all patent and legal formalities that could otherwise cost you a lot of time. Of course, all this is done in close cooperation with you.

Important protection

In the start-up phase, the value of the company is mainly determined by the management and the position of the intellectual property. A good intellectual property strategy not only ensures the proper protection of your ideas, but is also important when exploiting them. Think of selling your idea or product to a commercial party or an IPO. V.O. supports and helps make choices that enable investment in the business.

Experience with starters

V.O. has extensive experience in working with high-tech and biotech start-ups. Many of our experts were themselves working within these types of companies or in the industry. As a result, we are familiar with the problems and challenges you face and can easily put ourselves in your situation. We can protect the value of your intellectual property in a way that suits your business, no matter what stage of development your company is in.

Contact our experts

Michiel van Rooij

Michiel van Rooij

  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
More experts

News

Remembering Mark Einerhand

It is with great sadness that we have received the news of the passing, on 14 April, of our dear colleague and partner, Mark Einerhand. Mark joined V.O. in 1998 and has made a lasting contribution to the success of our firm.Continue reading

Validation agreement with Laos in force

As of 1 April 2025, the validation agreement between the European Patent Office (EPO) and the Lao PDR has entered into force. As a result, granted European patents can now be validated in Laos according to that country’s national patent law.Continue reading

Column: Can I only get a patent for breakthrough inventions?

In my work as a patent attorney, I notice that there is a lot of confusion among inventors about the requirements for a patent. Many inventors seem to be under the impression that patents are only granted for “breakthrough inventions”, such as the mRNA technology underlying – among others – the Covid vaccines, or novel […]Continue reading

Events

JCI Award Flemish-Brabant Young Entrepreneur 2025

Arcade Leuven, De Hoorn, Sluisstraat 79, 3000 Leuven, Belgium

Every year JCI (Junior Chamber International) Leuven and JCI Brussels award a young entrepreneur from Flemish Brabant or Brussels who has given shape to sustainable entrepreneurship in an exceptional way and dares to challenge society. In this way they hope to inspire a new generation of young potentials to become entrepreneurs while supporting young entrepreneurship in Flemish Brabant and Brussels.

Continue reading

NL Startup Competition 2025

3089 JB Rotterdam, Netherlands

In April and May the second edition of NL Startup Competition, organized by Erasmus Enterprises, will take place. An extraordinary opportunity for innovative talents who take up the challenge to pitch their startup for prize money, a valuable network and knowledge.

Continue reading

Knowledge for Growth 2025

Flanders Meeting & Convention Center Antwerp, Koningin Astridplein, Antwerpen, Belgium

The crème de la crème of the Belgian life sciences community is present at flanders.bio's annual Knowledge for Growth conference, which brings together decision-makers from the biotech, pharma and medtech, agriculture and chemical industries, as well as investors, universities, top research institutions, policy makers and competence providers.

Continue reading